54 related articles for article (PubMed ID: 2577259)
1. N-ras mutation in chemically induced rat brain tumour.
Rády P; Kinsella AR; Fox M; Arany I; Kertai P
Acta Biochim Biophys Hung; 1989; 24(4):313-6. PubMed ID: 2577259
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
3. Restriction fragment length polymorphisms in the rat N-ras and retinoblastoma genes: their identification and characterization.
Shepel LA; Gorski J
Oncogene; 1990 Nov; 5(11):1675-82. PubMed ID: 1980008
[TBL] [Abstract][Full Text] [Related]
4. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
5. Relationship of polymorphisms near the rat prolactin, N-ras, and retinoblastoma genes with susceptibility to estrogen-induced pituitary tumors.
Shepel LA; Gorski J
Cancer Res; 1990 Dec; 50(24):7920-5. PubMed ID: 1979252
[TBL] [Abstract][Full Text] [Related]
6. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
7. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
8. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
9. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
10. [Low incidence of point mutation of N-ras oncogene in human gliomas].
Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
[TBL] [Abstract][Full Text] [Related]
11. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
[TBL] [Abstract][Full Text] [Related]
12. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
13. Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors.
Higinbotham KG; Rice JM; Buzard GS; Perantoni AO
Oncogene; 1994 Sep; 9(9):2455-9. PubMed ID: 8058308
[TBL] [Abstract][Full Text] [Related]
14. Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.
Urban T; Ricci S; Danel C; Antoine M; Kambouchner M; Godard V; Lacave R; Bernaudin JF
Br J Cancer; 2000 Jan; 82(2):412-7. PubMed ID: 10646897
[TBL] [Abstract][Full Text] [Related]
15. RFLP analysis.
Beck HP
Methods Mol Med; 2002; 72():205-12. PubMed ID: 12125117
[No Abstract] [Full Text] [Related]
16. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
[No Abstract] [Full Text] [Related]
17. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ras gene mutations and methylation state in human leukemias.
Browett PJ; Norton JD
Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
[TBL] [Abstract][Full Text] [Related]
19. Activation of N-ras gene in a rat hepatocellular carcinoma induced by dibutylnitrosamine and butylated hydroxytoluene.
Funato T; Yokota J; Sakamoto H; Kameya T; Fukushima S; Ito N; Terada M; Sugimura T
Jpn J Cancer Res; 1987 Jul; 78(7):689-94. PubMed ID: 3040652
[TBL] [Abstract][Full Text] [Related]
20. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
